Related references
Note: Only part of the references are listed.Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Deborah P. Merke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
11-Oxygenated C19 Steroids Do Not Decline With Age in Women
Aya T. Nanba et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Congenital Adrenal Hyperplasia: Time to Replace 17OHP with 21-Deoxycortisol
Walter L. Miller
HORMONE RESEARCH IN PAEDIATRICS (2019)
Moving to a World Beyond p < 0.05
Ronald L. Wasserstein et al.
AMERICAN STATISTICIAN (2019)
Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society* Clinical Practice Guideline
Kathryn A. Martin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline
Phyllis W. Speiser et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome
Michael W. O'Reilly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
11-Oxygenated Androgens Are Biomarkers of Adrenal Volume and Testicular Adrenal Rest Tumors in 21-Hydroxylase Deficiency
Adina F. Turcu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Adrenal C11-oxy C21 steroids contribute to the C11-oxy C19 steroid pool via the backdoor pathway in the biosynthesis and metabolism of 21-deoxycortisol and 21-deoxycortisone
Lise Barnard et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
A new dawn for androgens: Novel lessons from 11-oxygenated C19 steroids
Elzette Pretorius et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency
Adina F. Turcu et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Development of a novel cell based androgen screening model
Carmela Campana et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
11-Ketotestosterone and 11-Ketodihydrotestosterone in Castration Resistant Prostate Cancer: Potent Androgens Which Can No Longer Be Ignored
Elzette Pretorius et al.
PLOS ONE (2016)
Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers
Miguel Debono et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Diala El-Maouche et al.
CLINICAL ENDOCRINOLOGY (2015)
Liquid Chromatography-Tandem Mass Spectrometry Analysis of Human Adrenal Vein 19-Carbon Steroids Before and After ACTH Stimulation
Juilee Rege et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
11β-Hydroxydihydrotestosterone and 11-ketodihydrotestosterone, novel C19 steroids with androgenic activity: A putative role in castration resistant prostate cancer?
Karl-Heinz Storbeck et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Clinical Characteristics of a Cohort of 244 Patients with Congenital Adrenal Hyperplasia
Gabriela P. Finkielstain et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Monitoring of Therapy in Congenital Adrenal Hyperplasia
Andrew Dauber et al.
CLINICAL CHEMISTRY (2010)
Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency
Flavia A. Costa-Barbosa et al.
CLINICAL ENDOCRINOLOGY (2010)
Preclinical challenges in steroid analysis of human samples
Uta Ceglarek et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
Share Paper
